Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy Complications | 2 | 2019 | 111 | 0.940 |
Why?
|
| Streptococcus agalactiae | 2 | 2022 | 12 | 0.840 |
Why?
|
| Streptococcal Infections | 2 | 2022 | 37 | 0.820 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2022 | 47 | 0.810 |
Why?
|
| Prenatal Care | 2 | 2020 | 41 | 0.790 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 131 | 0.780 |
Why?
|
| Pregnancy | 10 | 2022 | 1219 | 0.730 |
Why?
|
| Obstetric Labor, Premature | 1 | 2021 | 15 | 0.730 |
Why?
|
| Cervix Uteri | 1 | 2021 | 65 | 0.710 |
Why?
|
| Escherichia coli | 1 | 2021 | 338 | 0.600 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2019 | 17 | 0.590 |
Why?
|
| Methamphetamine | 1 | 2019 | 21 | 0.590 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 33 | 0.580 |
Why?
|
| Umbilical Cord | 1 | 2014 | 35 | 0.440 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 39 | 0.440 |
Why?
|
| Amniocentesis | 1 | 2013 | 3 | 0.420 |
Why?
|
| Anesthesia, Local | 1 | 2013 | 5 | 0.420 |
Why?
|
| Antirheumatic Agents | 1 | 2014 | 57 | 0.410 |
Why?
|
| Infant, Premature | 1 | 2014 | 144 | 0.410 |
Why?
|
| Pain Perception | 1 | 2013 | 17 | 0.410 |
Why?
|
| Biological Products | 1 | 2014 | 66 | 0.400 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2014 | 134 | 0.390 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 126 | 0.360 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2022 | 14 | 0.350 |
Why?
|
| Premature Birth | 2 | 2016 | 57 | 0.330 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 114 | 0.320 |
Why?
|
| Female | 10 | 2022 | 15472 | 0.310 |
Why?
|
| Humans | 11 | 2022 | 28585 | 0.260 |
Why?
|
| Adult | 6 | 2021 | 7922 | 0.260 |
Why?
|
| Gestational Age | 2 | 2020 | 146 | 0.260 |
Why?
|
| United States | 3 | 2020 | 2201 | 0.230 |
Why?
|
| Uterine Cervical Incompetence | 1 | 2004 | 2 | 0.230 |
Why?
|
| Cerclage, Cervical | 1 | 2004 | 3 | 0.230 |
Why?
|
| Young Adult | 4 | 2021 | 2804 | 0.210 |
Why?
|
| Pilot Projects | 2 | 2021 | 458 | 0.190 |
Why?
|
| Neonatal Sepsis | 1 | 2021 | 3 | 0.190 |
Why?
|
| Specimen Handling | 1 | 2022 | 33 | 0.180 |
Why?
|
| Escherichia coli Infections | 1 | 2021 | 45 | 0.180 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 44 | 0.180 |
Why?
|
| Genome, Bacterial | 1 | 2021 | 72 | 0.180 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2021 | 148 | 0.170 |
Why?
|
| Mass Screening | 1 | 2022 | 156 | 0.170 |
Why?
|
| Infant, Newborn | 2 | 2021 | 899 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2021 | 1272 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2021 | 256 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2020 | 93 | 0.160 |
Why?
|
| Cell Line | 1 | 2021 | 698 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 38 | 0.160 |
Why?
|
| Obstetrics | 1 | 2020 | 51 | 0.160 |
Why?
|
| Phylogeny | 1 | 2021 | 489 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 244 | 0.150 |
Why?
|
| Gastroschisis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 534 | 0.130 |
Why?
|
| Hydroxyprogesterones | 1 | 2016 | 1 | 0.130 |
Why?
|
| Progestins | 1 | 2016 | 12 | 0.120 |
Why?
|
| Hematocrit | 1 | 2014 | 26 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2014 | 12 | 0.110 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2014 | 11 | 0.110 |
Why?
|
| Preconception Care | 1 | 2014 | 17 | 0.110 |
Why?
|
| Lidocaine | 1 | 2013 | 27 | 0.100 |
Why?
|
| Placebos | 1 | 2013 | 48 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2013 | 68 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 247 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2013 | 421 | 0.090 |
Why?
|
| Adolescent | 2 | 2018 | 3165 | 0.090 |
Why?
|
| Time Factors | 1 | 2014 | 1600 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2004 | 241 | 0.050 |
Why?
|
| Perineum | 1 | 2022 | 14 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 50 | 0.050 |
Why?
|
| Vagina | 1 | 2022 | 42 | 0.050 |
Why?
|
| Logistic Models | 1 | 2018 | 409 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2016 | 12 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 22 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2016 | 32 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 175 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 732 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 770 | 0.030 |
Why?
|
| Risk Factors | 1 | 2018 | 2111 | 0.020 |
Why?
|